These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1657 related items for PubMed ID: 18046223

  • 21. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
    Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M.
    Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967
    [Abstract] [Full Text] [Related]

  • 22. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K.
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [Abstract] [Full Text] [Related]

  • 23. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H, Koss MJ, Singh P, Koch F.
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
    Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR.
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):483-9. PubMed ID: 17917738
    [Abstract] [Full Text] [Related]

  • 25. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A, Muftuoglu O, Altınsoy A, Ozkılıc E.
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [Abstract] [Full Text] [Related]

  • 26. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [Abstract] [Full Text] [Related]

  • 27. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
    Wang YS, Li X, Wang HY, Zhang ZF, Li MH, Su XN.
    Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
    [Abstract] [Full Text] [Related]

  • 28. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
    Soheilian M, Rabbanikhah Z, Ramezani A, Kiavash V, Yaseri M, Peyman GA.
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):199-206. PubMed ID: 20307215
    [Abstract] [Full Text] [Related]

  • 30. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [Abstract] [Full Text] [Related]

  • 31. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW, Park SC, Cho HY, Kang JH.
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [Abstract] [Full Text] [Related]

  • 32. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ohji M.
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [Abstract] [Full Text] [Related]

  • 33. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.
    J Diabetes Complications; 2006 Jun; 20(4):246-51. PubMed ID: 16798476
    [Abstract] [Full Text] [Related]

  • 34. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.
    Sobaci G, Ozge G, Erdurman C, Durukan HA, Bayraktar ZM.
    Ophthalmologica; 2012 Jun; 227(2):95-9. PubMed ID: 21893972
    [Abstract] [Full Text] [Related]

  • 35. Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy.
    Cho WB, Moon JW, Kim HC.
    Br J Ophthalmol; 2010 Jul; 94(7):858-63. PubMed ID: 20606024
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M, Shahrzad SS, Banifatemi M.
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 83.